跳至主要内容
临床试验/NCT03866772
NCT03866772终止不适用

Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both. Multicenter Randomized Controlled Trial- IDOM Trial

Bnai Zion Medical Center1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
250
试验地点
1
主要终点
the rate of cesarean delivery

研究概览

简要总结

The aim of this study is to compare the rate of cesarean delivery between 3 methods of labor induction: double balloon device, oral misoprostol and combination of the two.

详细描述

Induction of labor is a common obstetrical procedure. It accounts for 20% of laboring women worldwide.

In the past, studies showed that cesarean delivery rates (CDR) are higher in women who are induced. These studies were comparing induction to spontaneous labor, which is not the management in practice, and when the comparison was made between induction and expectant management, the conclusion was that the induction does not increase CDR and can even reduce its' rate.

Failure of induction depends on the definition, and even among randomized controlled trials, this definition may vary greatly.

The decision whether to use a mechanical or pharmacological agent depends on Bishop score, parity, contraindications to one of the methods and patient-doctor preference.

Recently, more data are available regarding induction with oral misoprostol (OM) and this method is becoming more popular because OM is effective, safe, convenient, cheap and easy to administer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • unfavourable cervix (Bishop score ≤ 4),
  • indication for induction of labor (medical or obstetrical),
  • 37 completed gestational weeks,
  • vertex presentation,
  • singleton pregnancy
  • intact membranes.

排除标准

  • previous cesarean delivery
  • previous uterine surgery (eg: myomectomy)
  • noncephalic presentation
  • multiple pregnancy
  • pre-eclampsia with severe features
  • oligohydramnios (Maximal vertical pocket ≤2)
  • estimated fetal weight <10% percentile
  • any contraindication to Vaginal delivery

研究组 & 干预措施

MISOPROSTOL

Active Comparator
  • oral misoprostol, 50 microgram, every 4 hours
  • Repeat treatment every 4 hours until active labour begins: regular painful contractions (≥ 3 in 10 min), cervical dilatation ≥ 3 cm
  • maximal number of doses: 6
  • Oxytocin infusion can be initiated 4 hours after the last dose of Misoprostol.
  • Failure of induction will be considered if no cervical change nor uterine contractions have begun during 24 hours of treatment.
  • Electronic fetal monitoring should be performed for 30 min after administration of misoprostol and 60 min after any tachysystole.

干预措施: Misoprostol Oral Tablet (Drug)

DOUBLE BALLOON

Active Comparator
  • Insertion of the DBD as instructed by the manufacturer, removal after 6 hours.
  • Artificial rupture of membranes (AROM) if suitable + IV oxytocin administration
  • If AROM cannot be performed- oxytocin infusion will be initiated at first.
  • If Bishop <3 after DBD removal, clinical evaluation and lag time before considering other methods for ripening is suitable and is up to the physician on call.

干预措施: double balloon device for cervical ripening (Device)

MISOPROSTOL+DOUBLE BALLOON

Active Comparator

干预措施: Misoprostol Oral Tablet (Drug)

MISOPROSTOL+DOUBLE BALLOON

Active Comparator

干预措施: double balloon device for cervical ripening (Device)

结局指标

主要结局

the rate of cesarean delivery

时间窗: from induction until delivery

percentage of cesarean delivery from all deliveries

次要结局

  • Bishop score difference between groups(after 6 hours and after 24 hours)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Inna.bleicher

principle investigator

Bnai Zion Medical Center

研究点 (1)

Loading locations...

相似试验